Testicular cancer incidence statistics

Cases

New cases of testicular cancer, 2017-2019, UK

 

Proportion of all cases

Percentage testicular cancer is of total cancer cases, 2017-2019, UK

 

Age

Peak rate of testicular cancer cases, 2017-2019, UK

 

Trend over time

Change in testicular cancer incidence rates since the early 1990s, Males, UK

 

Testicular cancer is the 17th most common cancer in males in the UK, accounting for 1% of all new cancer cases in males (2017-2019). In females and males combined, testicular cancer is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017-2019).[1-4]

Testicular cancer incidence rates (European age-standardised (AS) rate Open a glossary item) for males are similar to the UK average in all the UK constituent countries.

Testicular Cancer (C62), Average Number of New Cases Per Year, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Male Population, UK, 2017-2019

  England Scotland Wales Northern Ireland UK
Male Cases 1,994 211 102 68 2,376
Crude Rate 7.2 8.0 6.6 7.4 7.2
AS Rate 7.2 7.9 7.0 7.5 7.3
AS Rate - 95% LCL 7.0 7.3 6.2 6.5 7.1
AS Rate - 95% UCL 7.4 8.6 7.7 8.5 7.4
Persons Cases 1,994 211 102 68 2,376
Crude Rate 3.6 3.9 3.3 3.6 3.6
AS Rate 3.6 3.9 3.5 3.7 3.6
AS Rate - 95% LCL 3.5 3.6 3.1 3.2 3.5
AS Rate - 95% UCL 3.7 4.2 3.8 4.2 3.7
95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

About this data

Data is for UK, 2017-2019, ICD-10 C62

Last reviewed:

In the UK in 2017-2019, on average each year only 1% of new cases (1%) were in males aged 75 and over.[1-4] This is a much lower proportion of cases in older age groups compared with most cancers.

Age-specific incidence rates rise steeply from age 15-19, peak at age 30-34 and then decline rapidly. The highest rates are in the 30 to 34 age group.

Testicular Cancer (C62), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Male Population, UK, 2017-2019

The age distribution of testicular cancer cases may reflect an association with pubertal hormones.

See also

Testicular cancer mortality statistics by age

Testicular cancer survival statistics by age

Cancer incidence statistics by age for all cancers

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

About this data

Data is for UK, 2017-2019, ICD-10 C62.

Last reviewed:

Testicular cancer European age-standardised (AS) Open a glossary item incidence rates for males increased by 27% in the UK between 1993-1995 and 2017-2019.[1-4]

Over the last decade in the UK (between 2007-2009 and 2017-2019), testicular cancer AS incidence rates for males increased by 6%.

Testicular Cancer (ICD-10 C62), European Age-Standardised Incidence Rates, Male Population, 1993 to 2019

Testicular cancer incidence rates have varied between age groups in males in the UK since the early 1990s.[1-4] Rates in 0-24s have remained stable, in 25-49s have increased by 29%, in 50-59s have increased by 55%, in 60-69s have increased by 51%, in 70-79s have remained stable and in 80+s have remained stable.

Testicular Cancer (ICD-10 C62), European Age-Standardised Incidence Rates per 100,000 Male Population, By Age, UK, 1993-2019

Testicular cancer incidence trends are difficult to explain in terms of prevalence of risk factors or changes in diagnostic techniques or data recording.

References

  1. England data were provided by the National Cancer Registration and Analysis Service (NCRAS), part of the National Disease Registration Service (NDRS) in NHS England, on request through the Office for Data Release, January 2023. Similar data can be found here: https://www.cancerdata.nhs.uk/ 

  2.  Northern Ireland data were provided by the Northern Ireland Cancer Registry (NICR) on request, October 2021. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/. 

  3. Welsh data were published by the Welsh Cancer Intelligence and Surveillance Unit (WCISU), Health Intelligence Division, Public Health Wales https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-reporting-tool-official-statistics/ June 2022. 

  4. Scotland data were provided by the Scottish Cancer Registry, Public Health Scotland (PHS) on request, May 2021. Similar data can be found here: https://publichealthscotland.scot/publications/show-all-releases?id=20468

About this data

Data is for UK, 1993-2019, ICD-10 C62.

Last reviewed:

The most common specific location for testicular cancers in the UK is descended testes (2016-2018).[1-4] Variation of incidence by anatomical site may reflect the physical size of each site, and differences in risk factor exposure by site, among other factors.

Download this data

Cases and percentages may not sum due to rounding

See also

Find out more about the counting and coding of this data

Risk of cancer in undescended testicles (cryptorchidism)

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021. Similar data can be found here: https://www.ons.gov.uk
  2. Data were provided by ISD Scotland on request, April 2020. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were published by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales, March 2021. https://phw.nhs.wales/services-and-teams/welsh-cancer-intelligence-and-surveillance-unit-wcisu/cancer-incidence-in-wales-2002-2018/.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2020. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/

About this data

Data is for UK, 2016-2018, ICD-10 C62. For some cases the specific location of the cancer is not recorded, this may be due to clinical or data recording factors.

Last reviewed:

The number of new testicular cancer cases in males on average each year in the UK is projected to fall from around 2,400 cases in 2023-2025 to around 2,300 cases in 2038-2040.[1]

Testicular cancer incidence rates are projected to fall by 6% in the UK between 2023-2025 and 2038-2040, to 7 cases per 100,000 males on average each year by 2038-2040.[1]

Testicular cancer (C62), Observed and Projected Age-Standardised Incidence Rates, UK, 1993-2040

Download the data table (xlsx)

See also

Find out how these projections were calculated

Incidence trends over time for testicular cancer

Projections of incidence for all cancers combined

Testicular cancer risk

Download the projections data table

References

Calculated by the Cancer Intelligence Team at Cancer Research UK, February 2023. Age-period-cohort modelling approach described here, using 2020-based population projections (Office for National Statistics) and observed cancer incidence (1975-2018 for England, Scotland and Wales, 1993-2018 for Northern Ireland).

About this data

Projections are based on incidence data from 1975-2018 (England, Scotland and Wales) and 1993-2018 (Northern Ireland); the above figure presents all UK data from 1993-2018 (observed) and 2019-2040 (projected). Number of new cases and age-standardised rates are presented as annual averages for each 3-year rolling period. ICD-10 codes C62.

Projections are based on observed incidence rates and therefore implicitly include changes in cancer risk factors and diagnosis. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

Testicular cancer incidence rates (European age-standardised (AS) rates Open a glossary item) in England in males are 16% lower in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 190 more cases of testicular cancer each year in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile.

Testicular Cancer (C62), Estimated Average Number of Fewer Cases per Year, by Deprivation Quintile, England, 2013-2017

Testicular Cancer (C62), European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

See also

Data table: Cancer incidence rates and excess cases by cancer type in England

Incidence by deprivation for all cancer types combined

Testicular cancer mortality by deprivation  (not directly comparable with incidence by deprivation)

Cancer incidence by deprivation for Scotland

Cancer incidence by deprivation for Wales

Cancer incidence by deprivation for Northern Ireland

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C62.

Last reviewed:

An estimated 34,900 people who had been diagnosed with testicular cancer between 1991 and 2010 were alive in the UK at the end of 2010.[1]

See also

Testicular cancer incidence statistics by sex and UK country

What is prevalence?

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables. London: NCRAS; 2015.

About this data

Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C62

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.